Andrew C. Miller, MD | Authors

Clinical and Pathological Features Are Still the Best Determinants of Prognosis in Mesothelioma

December 18, 2012

Significant advances have been made in our understanding of the factors affecting the prognosis of malignant mesothelioma, and a number of biomarkers appear promising. However, at present it may be more fruitful to better define and characterize clinical factors that are well recognized as significantly impacting patient survival.